Exane Derivatives’s Bunge Global BG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$421K Sell
4,639
-6,630
-59% -$736K 0.24% 106
2022
Q1
$1.25M Sell
11,269
-950
-8% -$97.3K 0.35% 66
2021
Q4
$1.14M Buy
12,219
+3,417
+39% +$305K 0.28% 75
2021
Q3
$716K Buy
8,802
+7,574
+617% +$585K 0.17% 130
2021
Q2
$93.7K Sell
1,228
-5,727
-82% -$483K 0.02% 543
2021
Q1
$551K Sell
6,955
-2,013
-22% -$150K 0.16% 136
2020
Q4
$588K Sell
8,968
-13,589
-60% -$793K 0.17% 124
2020
Q3
$1.03M Buy
+22,557
New +$1.01M 0.3% 77

Other funds holding BG

Exane Derivatives's BG Position: Q2 2022 in Review

Exane Derivatives reduced its Bunge Global (BG) stake by 59% in Q2 2022, selling an estimated $736K and leaving 4,639 shares worth $421K. The position accounts for 0.24% of the portfolio, ranked #106.

Exane Derivatives first reported a position in BG in Q3 2020 and has held it in 8 quarters since. The position peaked at $1.25M in Q1 2022. 599 funds tracked by Wall St. Rank hold BG as of Q2 2022.

  • Exane Derivatives held 4,639 shares of Bunge Global worth $421K as of Q2 2022.
  • Exane Derivatives sold 6,630 Bunge Global shares in Q2 2022, an estimated $736K.
  • Bunge Global made up 0.24% of Exane Derivatives's portfolio in Q2 2022, its #106 holding.
  • Exane Derivatives first reported a position in Bunge Global in Q3 2020 and has held it in 8 quarters since.
  • Exane Derivatives's Bunge Global position peaked at $1.25M in Q1 2022.
  • 599 funds tracked by Wall St. Rank held Bunge Global as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.